Compare
Pharma-Bio Serv, Inc. vs Information Services Group Inc. vs TSS, Inc. vs Hackett Group, Inc.
| Latest fiscal year | Pharma-Bio Serv, Inc. PBSV | Information Services Group Inc. III | TSS, Inc. TSSI | Hackett Group, Inc. HCKT |
|---|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-31 | 2025-12-31 | 2025-12-26 |
| Revenue | $9.00M | $244.72M | $245.72M | $305.63M |
| Revenue growth (YoY) | -5.3% | -1.2% | +65.9% | -2.6% |
| Gross margin | 32.3% | 43.1% (computed) | 13.2% | 38.3% (computed) |
| Operating margin | -7.1% | 7.3% | 2.6% | 7.7% |
| Net margin | -1.1% | 3.8% | 6.2% | 4.2% |
| Net income | -$100.5K | $9.34M | $15.12M | $12.94M |
| EPS (Diluted) | $0.00 | $0.19 | $0.56 | $0.46 |
| Operating cash flow | -$214.9K | $29.01M | $34.86M | $40.30M |
| Free cash flow | -$221.5K | $24.99M | $2.12M | $32.44M |
| Cash & equivalents | n/a | $28.66M | $85.51M | $18.20M |
| Total assets | $13.65M | $211.00M | $184.94M | $206.45M |
| Total liabilities | $1.74M | $116.33M | $108.30M | $138.35M |
| Shareholders' equity | $11.91M | $94.68M | $76.64M | $68.10M |
| Return on year-end equity | -0.8% | 9.9% | 19.7% | 19.0% |
| Shares outstanding | 22.91M | 47.77M | 27.59M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Pharma-Bio Serv, Inc. | Information Services Group Inc. | TSS, Inc. | Hackett Group, Inc. |
|---|---|---|---|---|
| Latest | $9.00M Ended 2025-10-31 | $244.72M Ended 2025-12-31 | $245.72M Ended 2025-12-31 | $305.63M Ended 2025-12-26 |
| 1 year earlier | $9.51M Ended 2024-10-31 | $247.59M Ended 2024-12-31 | $148.14M Ended 2024-12-31 | $313.86M Ended 2024-12-27 |
| 2 years earlier | $16.98M Ended 2023-10-31 | $291.05M Ended 2023-12-31 | $54.40M Ended 2023-12-31 | $296.59M Ended 2023-12-29 |
| 3 years earlier | $19.40M Ended 2022-10-31 | $286.27M Ended 2022-12-31 | $30.64M Ended 2022-12-31 | $293.74M Ended 2022-12-30 |
| 4 years earlier | $20.12M Ended 2021-10-31 | $277.83M Ended 2021-12-31 | $27.41M Ended 2021-12-31 | $278.81M Ended 2021-12-31 |